Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

david_webb_mhra

MHRA appoints three directors to its Board

July 31, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, MHRA

The Department of Health has announced that three new non-executive directors are joining the Medicines and Healthcare Products Regulatory Agency. …
Appointment

January deadline for Pfizer restructure

July 30, 2013 Research and Development, Sales and Marketing Pfizer, patent, restructure

Pfizer is to restructure operations from January 2014 in a bid to make its business more responsive to patient and …
News
CISplatin image

Nearly all UK men survive testicular cancer

July 30, 2013 Research and Development, Sales and Marketing

Survival for testicular cancer has risen by almost 30% in the last 40 years, with nearly all men now beating …
News
Elan image

Perrigo pays $8.6 billion for Elan

July 30, 2013 Research and Development, Sales and Marketing Elan, Perrigo, Tysabri

Generics firm Perrigo has snapped up Ireland-based Elan in a multi-billion dollar deal, ending a bitter takeover battle that has …
News

Aesica appoints Chris Gowland to the Board

July 30, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Aesica, Chris Gowland

Contract development and manufacturing organisation Aesica has appointed Chris Gowland to the newly formed position of chief operating officer. As …
Appointment
Shanghai image

Patients and profits – time for new priorities

July 29, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, McConaghie, andrew, pharma, profits

Pharmaceutical journalists don’t retire, they just go off patent. Well, I’m not retiring as such, but after ten years as …
Feature
EMA image

EMA: no cancer risk from GLP-1s

July 29, 2013 Research and Development, Sales and Marketing Cancer, EMA, GLP-1s

One of the European Medicines Agency’s key advisory groups has decided that concerns over an increased cancer risk with some …
News
tim_roberts

PCI hires associate director of Clinical Trials

July 29, 2013 Manufacturing and Production, Research and Development, Sales and Marketing

Pharma packaging and clinical trials services firm PCI has appointed Tim Roberts as an associate director of Clinical Trials.The changes …
Appointment

Contract research news in brief

July 26, 2013 Research and Development Ascendancy Healthcare, CRO Solutions, Clinical Research Advantage, ResearchDx, SPS Pharma Services, VxP Pharma

Quintiles wins multi-year contract in China, CRO Solutions sets up niche subsidiary and CRA buys CNS unit, plus relocations for …
News
Lonza image

Teva and Lonza abandon biosimilars joint venture

July 26, 2013 Manufacturing and Production, Research and Development CMO, Levin, Lonza, Teva, biosimilars

Escalating costs have led Teva and contract manufacturing organisation (CMO) Lonza to abandon a joint venture set up in 2009 …
News
finbarr-martin-bw

Two non-executive directors join NICE Board

July 26, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NICE, finbarr martin, mumford

The Department of Health has announced that two new non-executive directors will join the National Institute for Health and Care …
Appointment
andrew_monaghan_chiltern__jul_2013

Chiltern hires Andrew Monaghan as director

July 25, 2013 Manufacturing and Production, Research and Development, Sales and Marketing CRO, chiltern, monaghan

Contract research organisation Chiltern has appointed Andrew Monaghan as its director of Global Pharmacovigilance. Monaghan has more than 30 years’ …
Appointment
lilly image

Transition Therapeutics buys into Lilly bone drug

July 24, 2013 Research and Development, Sales and Marketing Transition, bone, lilly

Transition Therapeutics has bought Lilly’s early-stage osteoarthritis drug TT-601 that is designed to help patients with chronic bone pain. Transition …
News
Roche image

New Roche leukaemia drug beats rival

July 24, 2013 Research and Development, Sales and Marketing Rituxan, Roche, leukaemia, obinutuzumab

Roche’s next generation leukaemia drug obinutuzumab has beaten the firm’s ageing blood cancer medicine Rituxan in a late-stage trial. The …
News
richard bergstrom image

Pharma groups want limited data release

July 24, 2013 Research and Development, Sales and Marketing EFPIA, Goldacre, PhRMA, all trials, transparency

The two main US and European pharma lobby groups have released a joint statement saying they welcome independent reviews of …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026